Gland Pharma Ltd. (GLAND) Pharma Share Price near 52-week high after 0.29% rise

Gland Pharma Share Price is trading at Rs 3,161, up 0.29% today, and remains near its 52-week high with a market capitalisation of Rs 49,617.11 crore.

Gland Pharma Share Price is trading at Rs 3,161 in early market action on 08 October 2026 at 9:22 AM IST, up Rs 9.05 or 0.29% from the previous close of Rs 3,151.95. The stock is staying close to its 52-week high after touching Rs 3,170.5 in the current session, while the market capitalisation stands at Rs 49,617.11 crore. According to latest Univest data, the price event is real and measurable, but it does not by itself establish a company-specific catalyst.

Gland Pharma Share Price Today: Price Action Analysis

The latest Gland Pharma Share Price move matters because it places Gland Pharma Ltd. (GLAND) near the yearly high zone while broader investor searches continue to cluster around Gland Pharma Share Price Today, Gland Pharma Stock News and Gland Pharma Share Price Live. The current price, the day range and the company’s market cap give a clear snapshot of where the stock stands today without adding any unsupported explanation. For readers tracking Gland Pharma Share Price, the next important checkpoints are valuation, sector comparison and company fundamentals.

Metric	Value
Current Price	Rs 3,161
Previous Close	Rs 3,151.95
Today's Move	+Rs 9.05 (+0.29%)
Open	Rs 3,161.35
High	Rs 3,170.5
Low	Rs 3,111
Market Capitalisation	Rs 49,617.11 crore

Gland Pharma Ltd. (GLAND) traded at Rs 3,161 versus the previous close of Rs 3,151.95, a rise of 0.29%. The stock opened at Rs 3,161.35, reached a high of Rs 3,170.5 and touched a low of Rs 3,111.

Gland Pharma Share Price opened at Rs 3,161.35 and moved between Rs 3,111 and Rs 3,170.5 so far in the session. The stock is trading at Rs 3,161, which is Rs 9.05 above the previous close of Rs 3,151.95. That keeps Gland Pharma Share Price close to its 52-week high and within a narrow distance of the session peak. For readers following Gland Pharma Share Price Today, the main factual takeaway is that the move is positive, modest and still attached to the one-year high discussion rather than a broader trend claim.

Gland Pharma Ltd. (GLAND) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 49,617.11 crore
P/E Ratio	46.08x
P/B Ratio	4.89x
ROE	10.56%
ROCE	14.96%
EPS	Rs 68.41
Book Value Per Share	Rs 644.16
Dividend Yield	0.63%

Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 46.08x, P/B 4.89x, ROE 10.56%, ROCE 14.96%. These figures provide context only and are not a buy or sell signal.

Gland Pharma Ltd. has a market capitalisation of Rs 49,617.11 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 46.08x, P/B at 4.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.63%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.91x, median ROE of 11.61%, median ROCE of 13.28%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	46.08x
Benchmark Median P/E	27.91x
Benchmark Average P/E	41.14x
Benchmark P/E Range	0x to 708.87x
Company P/B Ratio	4.89x
Benchmark Median P/B	2.81x
Company ROE	10.56%
Benchmark Median ROE	11.61%
Company ROCE	14.96%
Benchmark Median ROCE	13.28%
Company Market Capitalisation	Rs 49,617.11 crore
Benchmark Median Market Cap	Rs 828.13 crore

Gland Pharma Ltd. (GLAND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Gland Pharma Ltd. (GLAND) has a P/E ratio of 46.08x, which is above the benchmark median of 27.91x, a difference of +65.1%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.61%, a difference of -9.04%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.28%, a difference of +12.65%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ipca Laboratories Ltd.	IPCALAB	49,374.65	37.56	5.8	15.88	19.41
Anthem Biosciences Ltd.	ANTHEM	50,128.64	86.8	15.97	21.98	29.62
Glaxosmithkline Pharmaceuticals Ltd.	GLAXO	46,723.88	41.76	17.7	48.76	66.79
Ajanta Pharma Ltd.	AJANTPHARM	44,692.84	39.3	9.18	25.42	32.67
Abbott India Ltd.	ABBOTINDIA	55,522.09	34.33	10.71	34.67	46.72

Gland Pharma Ltd. (GLAND) has a P/E ratio of 46.08x compared with the displayed peer median of 39.3x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.56% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 49,617.11 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Gland Pharma

• Gland Pharma Share Price is trading at Rs 3,161, which is close to its 52-week high and above the previous close of Rs 3,151.95.
• The session range for Gland Pharma Share Price has run from Rs 3,111 to Rs 3,170.5, showing where the stock is moving today.
• Gland Pharma Share Price carries a market capitalisation of Rs 49,617.11 crore, keeping it among the larger companies in the peer set.
• The company’s P/E of 46.08 and P/B of 4.89 place Gland Pharma Share Price above the industry median on both measures.
• ROE of 10.56% and ROCE of 14.96% provide context for Gland Pharma Share Price alongside sector benchmarks and peers.

About Gland Pharma

Gland Pharma Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. Gland Pharma Share Price reflects market attention around a listed pharmaceutical company with a current market capitalisation of Rs 49,617.11 crore and financial ratios that can be compared with other companies in the same industry. The latest quarterly revenue cited for June 2026 was Rs 1,800.27 crore. For readers scanning Gland Pharma Stock News or Gland Pharma Company News, this is a company whose market data is being tracked closely within a broad Indian healthcare universe.

Frequently Asked Questions

Why is Gland Pharma Share Price in focus today?

Ans. Gland Pharma Share Price is in focus because it is trading near its 52-week high at Rs 3,161, with a 0.29% rise from the previous close. The move is measurable and current.

What is Gland Pharma Share Price today?

Ans. Gland Pharma Share Price is Rs 3,161 as of 08 October 2026 at 9:22 AM IST. It is above the previous close of Rs 3,151.95 and near the yearly high zone.

How far is Gland Pharma Share Price from its 52-week high?

Ans. Gland Pharma Share Price touched Rs 3,170.5 in the session, which places it close to the 52-week high area. The current price remains within that upper range, making the stock a near-high event.

What does Gland Pharma Share Price tell investors today? Is Gland Pharma Share Price expensive versus peers?

Ans. Gland Pharma Share Price has a P/E of 46.08 and a P/B of 4.89. Both stand above the same-industry median, so the stock is valued above typical peer benchmarks on those measures.

How does Gland Pharma Share Price compare on profitability?

Ans. Gland Pharma Share Price has ROE of 10.56% and ROCE of 14.96%. ROE is slightly below the industry median, while ROCE is above it, giving a mixed profitability picture.

What is the market cap behind Gland Pharma Share Price?

Ans. Gland Pharma Share Price corresponds to a market capitalisation of Rs 49,617.11 crore. That places the company well above the same-industry median market cap in the reference set.

Where can I track Gland Pharma Share Price updates?

Ans. Gland Pharma Share Price updates can be tracked on Univest, where readers can follow live price, 52-week levels, valuation ratios, financial results and sector comparison in one view.

Track Gland Pharma Share Price on Univest

Use Gland Pharma Ltd. (GLAND) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Gland Pharma Share Price on Univest for live price updates, valuation ratios, market capitalisation, 52-week levels, financial results, industry comparison and other market insights. Univest also helps users follow Gland Pharma Share Price Today, Gland Pharma Stock News and Gland Pharma Share Price Live in one place.